Capabilities Highlights: Innovative Solutions for Cell & Gene Therapy This document highlights Somru BioScience’s capabilities in providing innovative solutions for cell and gene therapy (CGT). They offer bioanalytical and drug development services, emphasizing their expertise in molecular biology, immunogenicity, and regulated bioanalytical platforms. Explore the Full Whitepaper ! Email Address * Name Powered by …
Pre-IND Planning for Biosimilar Development with Emphasis on Population PK This white paper from Somru BioScience focuses on the importance of early pre-Investigational New Drug (pre-IND) planning for biosimilar development, with a strong emphasis on Population Pharmacokinetics (PopPK). Key takeaways include: Importance of Pre-IND Planning: It’s a crucial foundational step for biosimilar development, establishing regulatory roadmaps, …
Pre-IND Planning for Biosimilar Development with Emphasis on Population PK Read More »
Population Pharmacokinetics (PopPK) in Biosimilar Studies: Purpose, Challenges, Solutions, and Case Study This white paper by Somru BioScience discusses the purpose, challenges, solutions, and a case study related to Population Pharmacokinetics (PopPK) modeling in biosimilar studies.Key points include:Purpose of PopPK: It assesses similarity between biosimilars and reference products, supports indication extrapolation, optimizes study design, and …
Population Pharmacokinetics (PopPK) in Biosimilar Studies: Read More »
Immunogenicity Prediction in Bi-Specific Antibody Engineering This white paper from Somru BioScience focuses on immunogenicity prediction in bi-specific antibody (bsAb) engineering. BsAbs, while powerful therapeutic proteins with dual-targeting capabilities, present unique immunogenicity challenges due to their complex structure. Explore the Full Whitepaper ! Email Address * Name Powered by weForms
Case Study: Application of In-Silico Immunogenicity Prediction at Lead Optimization Stage for Monoclonal Antibodies This white paper from Somru BioScience discusses the application of in-silico immunogenicity prediction during the lead optimization stage for monoclonal antibodies (mAbs). Explore the Full Whitepaper ! Email Address * Name Powered by weForms
Automating Report Generation with AI: Unlocking Efficiency in Life Sciences and Beyond This white paper from Somru BioScience discusses the automation of report generation using AI, particularly in the life sciences. It highlights that while AI is used in other areas of clinical trials, its application in report generation is still emerging. The paper outlines …
Automating Report Generation with AI: Unlocking Efficiency in Life Sciences and Beyond Read More »
AI-Driven QC Review: Enhancing Accuracy and Efficiency in Scientific Workflows This white paper from Somru BioScience discusses how AI can enhance Quality Control (QC) review in scientific workflows. Traditionally, QC reviews are manual, time-intensive, and prone to error. AI can modernize these processes by automating the analysis of worksheets, comparing them against standard methods, and …
AI-Driven QC Review: Enhancing Accuracy and Efficiency in Scientific Workflows Read More »
TDCC Assay: Revolutionizing Tumor Cell Cytotoxicity Assessment Discover how the TDCC (Target-Dependent Cell Cytotoxicity) assay offers a cutting-edge approach to evaluating antibody efficacy by accurately measuring immune-mediated tumor cell killing. This white paper explores the assay’s methodology, applications, and advantages in immuno-oncology research and therapeutic development. Explore the Full Whitepaper ! Email Address * Name …
Decoding Immunity: Advancements in Complement Activation Assays Dive into the latest innovations in complement activation assays, exploring precise methodologies and their pivotal role in evaluating immune responses for biotherapeutic development and safety assessments. Explore the Full Whitepaper ! Email Address * Name Powered by weForms
Bridging the AI Gap in Bioanalysis: Unlocking the Future of Drug Development This white paper explores the critical gap between current bioanalytical workflows and the transformative potential of artificial intelligence. It highlights challenges in data integration, regulatory acceptance, and cultural adoption—while outlining practical steps to accelerate AI implementation in pharmaceutical R&D and regulatory science. Explore …
Closing the AI Gap in Bioanalysis: Challenges and Opportunities Read More »